绥美凯什么时候会降价

Suimeike (dolute abalamib tablets) has strong competitiveness in the market: on the one hand, it combines several anti-HIV drugs with different mechanisms to achieve a combined treatment effect; on the other hand, it is convenient to take, which greatly increases the patient's compliance with taking the drug, makes it easier to be accepted by the patient, and reduces the impact of the patient's inability to take the drug on time and in the dose. Today let’s take a closer look at when Suimeikai will cut prices?

According to Medical Companion Travel, Suimeikai (Domitabalamid Tablets) has just been launched in China and has not yet been included in medical insurance, and it is not yet a medical insurance drug. Since Suimeike (Dolutea Paramid Tablets) is an imported original drug in China, it is very expensive and most patients cannot afford it. Therefore, many patients choose Suimeikai (Domitabalamid Tablets), which is available in India. Suimeike (Doteta abalami tablets) produced by the Indian company Emcure, comes in a box of 30 tablets, priced at approximately RMB 1,000. Due to the floating exchange rate, the price cannot be determined. Please consult Medical Travel for specific prices.

On January 22, 2018, GlaxoSmithKline (GSK) announced that its single-tablet compound preparation Trimeq (dolute abalamib tablets) with the new generation integrase inhibitor dolutegravir (DTG) as the core for the treatment of HIV was officially launched in mainland China. This is the first single-pill compound preparation with a complete treatment plan in the field of HIV treatment in mainland China.

Trimicay (dolutegravir) is a once-daily three-in-one drug developed by ViiV Healthcare, a joint venture between GlaxoSmithKline and Pfizer. The drug is based on the treatment plan of the integrase inhibitor Tivicay (Dolutegravir) and also contains two nucleoside reverse transcriptase inhibitors, Abacavir and Lamivudine. It was approved by the FDA on August 27, 2014.

Suimeike (dolutegravir tablets) is the only three-in-one compound drug containing dolutegravir (DTG). It has the characteristics of high efficacy, good tolerance, high resistance barrier, and few drug interactions. One tablet per day can significantly reduce the medication burden of AIDS patients, thereby improving patients' medication compliance and significantly improving their quality of life.

The above is the price content of Suimeikai (Doteta Abalamid Tablets), I hope it can help you!